|
|
Volumn 24, Issue 1, 2001, Pages 96-98
|
|
Phase II study of liposomal doxorubicin in patients with advanced colorectal cancer
|
|
Author keywords
Chemotherapy; Colon cancer; Doxorubicin; Liposomal
|
|
Indexed keywords
DOXORUBICIN;
LIPOSOME;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
BLOOD TOXICITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLORECTAL CANCER;
DOSE RESPONSE;
DRUG FORMULATION;
DRUG HYPERSENSITIVITY;
DRUG RESPONSE;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
MALE;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PREMEDICATION;
THROMBOCYTOPENIA;
ADULT;
AGED;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTIMETABOLITES, ANTINEOPLASTIC;
COLORECTAL NEOPLASMS;
DOXORUBICIN;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
FLUOROURACIL;
HUMANS;
LIPOSOMES;
MALE;
MIDDLE AGED;
|
|
EID: 0035117953
PISSN: 02773732
EISSN: None
Source Type: Journal
DOI: 10.1097/00000421-200102000-00019 Document Type: Article |
|
Times cited : (23)
|
|
References (11)
|
